RxDoctor Payments Data

Melissa Floyd, NP

Family Medicine · Covington, LANPI 1982248571

Payments from drug & device makers

$1,946in general payments, 2019–2025

Across 126 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$841
  • Lilly USA, LLC$306
  • AstraZeneca$195
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$136
  • Astellas Pharma US Inc$58
  • GSK$53
  • plus $358 from 15 others

What the payments were for

  • Food & beverage$1,946100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,946 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$517
Medicare patients
29
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide117$150,926
JardianceEmpagliflozin21$37,030
OzempicSemaglutide24$21,171
EliquisApixaban28$20,671
VraylarCariprazine Hcl12$16,708
JanuviaSitagliptin Phosphate17$15,851
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$15,185
LinzessLinaclotide24$12,311
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$7,405
MyrbetriqMirabegron12$6,112
Spiriva RespimatTiotropium Bromide12$5,953
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$4,933
Albuterol Sulfate HfaAlbuterol Sulfate71$3,286
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$1,685
Fluticasone Propionate94$776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$306$150,926117 claims
AbbVieVraylar, Linzess$841$29,01936 claims
Novo NordiskOzempic$18$21,17124 claims
AstraZenecaBreztri Aerosphere$195$15,18515 claims
GSKTrelegy Ellipta$53$7,40514 claims
Astellas Pharma US IncMyrbetriq$58$6,11212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →